hiprabovis ibr marker live
laboratorios hipra s.a - živjeti ets - tk - dual-gen-uklonjen goveđi herpes virus tip 1, soj ceddel: 106.3–107.3 ccid50 - immunologicals - stoka - za aktivna imunizacija goveda s tri mjeseca starosti goveda protiv virusa herpesa tipa 1 (bohv-1) za smanjenje kliničkih znakova infekcije ринотрахеита goveda (ИБР) i polje virus izlučivanje. početak imuniteta: 21 dan nakon završetka osnovne sheme cijepljenja. trajanje imuniteta: 6 mjeseci nakon završetka osnovne sheme cijepljenja .
abiraterone accord
accord healthcare s.l.u. - abirateron acetat - prostatske neoplazme - endokrinska terapija - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
abiraterone krka
krka, d.d., novo mesto - abirateron acetat - prostatske neoplazme - endokrinska terapija - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.
abiraterone mylan
mylan ireland limited - abirateron acetat - prostatske neoplazme - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
abirateron teva 500 mg/1 tableta filmom obložena tableta
pliva d.o.o.sarajevo - abirateron - filmom obložena tableta - 500 mg/1 tableta - 1 filmom obložena tableta sadrži: 500 mg abiraterona u obliku acetata
abiraterone pharmascience 500 mg/1 tableta filmom obložena tableta
evropa lijek pharma d.o.o. - abirateron - filmom obložena tableta - 500 mg/1 tableta - 1 filmom obložena tableta sadrži 500 mg abirateron acetata
abiraterone pharmascience 500 mg/1 tableta filmom obložena tableta
evropa lijek pharma d.o.o. - abirateron - filmom obložena tableta - 500 mg/1 tableta - 1 film obložena tableta sadrži 500 mg abirateron acetata
abiraterone accord 500 mg/1 tableta film tableta
pharmavision bh d.o.o. - abirateron - film tableta - 500 mg/1 tableta - 1 film tableta sadrži : 500 mg abirateron acetata
abiraterone accord 250 mg/1 tableta tableta
pharmavision bh d.o.o. - abirateron - tableta - 250 mg/1 tableta - 1 tableta sadrži : 250 mg abirateron acetata
abiraterone accord 500 mg/1 tableta film tableta
pharmavision bh d.o.o. - abirateron - film tableta - 500 mg/1 tableta - 1 film tableta sadrži : 500 mg abirateron acetata